Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome

ISME Journal

Volumn 10, Issue 6, 2016, Pages 1483-1498

  Quinn, Robert A ^a,b   Phelan, Vanessa V ^b   Whiteson, Katrine L ^c   Garg, Neha ^b   Bailey, Barbara A ^a   Lim, Yan Wei ^a   Conrad, Douglas J ^d   Dorrestein, Pieter C ^b   Rohwer, Forest L ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM; BIOCHEMISTRY; GENE; GENETIC ANALYSIS; HOST USE; LIPID; METABOLITE; MICROBIAL COMMUNITY; MUCUS; PATHOGEN; XENOBIOTICS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

2-HEPTYL-3-HYDROXY-4-QUINOLONE; CERAMIDE; QUINOLONE DERIVATIVE; RNA 16S; XENOBIOTIC AGENT;

ADOLESCENT; CHEMISTRY; CYSTIC FIBROSIS; GENETICS; HUMAN; LUNG; METABOLISM; METABOLOME; MICROBIOLOGY; MICROFLORA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SPUTUM;

ADOLESCENT; CERAMIDES; CYSTIC FIBROSIS; HUMANS; LUNG; METABOLOME; MICROBIOTA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUINOLONES; RNA, RIBOSOMAL, 16S; SPUTUM; XENOBIOTICS;

EID: 84949604733     PISSN: 17517362     EISSN: 17517370     Source Type: Journal    
DOI: 10.1038/ismej.2015.207     Document Type: Article

References (99)

1. Allen L, Dockrell DH, Pattery T, Lee DG, Cornelis P, Hellewell PG, et al. (2005). Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J Immunol 174: 3643-3649
2. Ammit AJ, Hastie AT, Edsall LC, Hoffman RK, Amrani Y, Krymskaya VP, et al. (2001). Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J 15: 1212-1214
3. Bandeira N, Tsur D, Frank A, Pevzner PA. (2007). Protein identification by spectral networks analysis. Proc Natl Acad Sci USA 104: 6140-6145
4. Barker M, Hengst M, Schmid J, Buers H-J, Mittermaier B, Klemp D, et al. (2006). Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Eur Respir J 27: 929-936
5. Behrends V, Ryall B, Zlosnik JE, Speert DP, Bundy JG, Williams HD. (2013). Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environ Microbiol 15: 398-408
6. Bensel T, Stotz M, Borneff-Lipp M, Wollschläger B, Wienke A, Taccetti G, et al. (2011). Lactate in cystic fibrosis sputum. J Cyst Fibros 10: 37-44
7. Blainey PC, Milla CE, Cornfield DN, Quake SR. (2012). Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med 4: 153ra130
8. Bodas M, Min T, Mazur S, Vij N. (2011). Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema. J Immunol 186: 602-613
9. Bredenbruch F, Geffers R, Nimtz M, Buer J, Häussler S. (2006). The Pseudomonas aeruginosa quinolone signal (PQS) has an iron-chelating activity. Environ Microbiol 8: 1318-1329
10. Brodlie M, Lordan JL, Ward C. (2011). Ceramide and cystic fibrosis lung disease.AmJ Respir Crit CareMed 183: 133
11. Calfee MW, Coleman JP, Pesci EC. (2001). Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa. Proc Natl Acad Sci USA 98: 11633-11637
12. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. (2011). Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA 108: 4516-4522
13. Celio S, Troxler H, Durka SS, Chládek J, Wildhaber JH, Sennhauser FH, et al. (2006). Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma. Nitric Oxide 15: 226-232
14. Cole JR, Chai B, Farris RJ, Wang Q, Kulam SA, McGarrell DM, et al. (2005). The Ribosomal Database Project (RDP-II): sequences and tools for high-Throughput rRNA analysis. Nucleic Acids Res 33: D294-D296
15. Collier DN, Anderson L, McKnight SL, Noah TL, Knowles M, Boucher R, et al. (2002). A bacterial cell to cell signal in the lungs of cystic fibrosis patients. FEMS Microbiol Lett 215: 41-46
16. Cuthbertson L, Rogers GB, Walker AW, Oliver A, Hafiz T, Hoffman LR, et al. (2014). Time between collection and storage significantly influences bacterial sequence composition in sputum samples from cystic fibrosis respiratory infections. J Clin Microbiol 52: 3011-3016
17. Dechecchi MC, Nicolis E, Mazzi P, Cioffi F, Bezzerri V, Lampronti I, et al. (2011). Modulators of sphingolipid metabolism reduce lung inflammation. Am J Respir Cell Mol Biol 45: 825-833
18. Delhaes L, Monchy S, Fréalle E, Hubans C, Salleron J, Leroy S, et al. (2012). The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS One 7: e36313
19. Dettmer K, Aronov PA, Hammock BD. (2007). Mass spectrometry-based metabolomics. Mass Spectrom Rev 26: 51-78
20. Diggle SP, Matthijs S, Wright VJ, Fletcher MP, Chhabra SR, Lamont IL, et al. (2007). The Pseudomonas aeruginosa 4-quinolone signal molecules HHQ and PQS play multifunctional roles in quorum sensing and iron entrapment. Chem Biol 14: 87-96
21. Eiserich JP, Yang J, Morrissey BM, Hammock BD, Cross CE. (2012). Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions. Ann NY Acad Sci 1259: 1-9
22. Filkins LM, Hampton TH, Gifford AH, Gross MJ, Hogan DA, Sogin ML, et al. (2012). Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol 194: 4709-4717
23. Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, et al. (2010). Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J Med Microbiol 59: 1089-1100
24. Ghio AJ, Roggli VL, Soukup JM, Richards JH, Randell SH, Muhlebach MS. (2012). Iron accumulates in the lavage and explanted lungs of cystic fibrosis patients. J Cyst Fibros 12: 390-398
25. Goddard AF, Staudinger BJ, Dowd SE, Joshi-Datar A, Wolcott RD, Aitken ML, et al. (2012). Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-Airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci USA 109: 13769-13774
26. Guss AM, Roeselers G, Newton ILG, Young CR, Klepac-Ceraj V, Lory S, et al. (2011). Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J 5: 20-29
27. Hare NJ, Soe CZ, Rose B, Harbour C, Codd R, Manos J, et al. (2012). Proteomics of Pseudomonas aeruginosa Australian epidemic strain 1 (AES-1) cultured under conditions mimicking the cystic fibrosis lung reveals increased iron acquisition via the siderophore pyochelin. J Proteome Res 11: 776-795
28. Harrison F. (2007). Microbial ecology of the cystic fibrosis lung. Microbiology 153: 917-923
29. Häussler S, Becker T. (2008). The pseudomonas quinolone signal (PQS) balances life and death in Pseudomonas aeruginosa populations. PLoS Pathog 4: e1000166
30. Heeb S, Fletcher MP, Chhabra SR, Diggle SP, Williams P, Cámara M. (2011). Quinolones: from antibiotics to autoinducers. FEMS Microbiol Rev 35: 247-274
31. Hogardt M, Heesemann J. (2010). Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int J Med Microbiol 300: 557-562
32. Hu Y, Coates A. (2012). Nonmultiplying bacteria are profoundly tolerant to antibiotics. Handb Exp Pharmacol 211: 99-119
33. Hunter RC, Klepac-Ceraj V, Lorenzi MM, Grotzinger H, Martin TR, Newman DK. (2012). Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am J Respir Cell Mol Biol 47: 738-745
34. Irie Y, Otoole GA, Yuk MH. (2005). Pseudomonas aeruginosa rhamnolipids disperse Bordetella bronchiseptica biofilms. FEMS Microbiol Lett 250: 237-243
35. Jones KL, Hegab AH, Hillman BC, Simpson KL, Jinkins PA, Grisham MB, et al. (2000). Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr Pulmonol 30: 79-85
36. Knowles MR, Stutts MJ, Spock A, Fischer N, Gatzy JT, Boucher RC. (1983). Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221: 1067-1070
37. Kownatzki R, Tümmler B, Döring G. (1987). Rhamnolipid of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. Lancet 1: 1026-1027
38. Lim YW, Evangelista JS, Schmieder R, Bailey B, Haynes M, Furlan M, et al. (2014). Clinical insights from metagenomic analysis of cystic fibrosis sputum. J Clin Microbiol 52: 425-457
39. Lim YW, Schmieder R, Haynes M, Willner D, Furlan M, Youle M, et al. (2013). Metagenomics and metatranscriptomics: Windows on CF-Associated viral and microbial communities. J Cyst Fibros 12: 154-164
40. Macher B, Klock J. (1980). Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils. J Biol Chem 255: 2092-2096
41. Maughan H, Wang PW, Diaz Caballero J, Fung P, Gong Y, Donaldson SL, et al. (2012). Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions. PLoS One 7: e45791
42. Mitchell G, Séguin DL, Asselin A-E, Déziel E, Cantin AM, Frost EH, et al. (2010). Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide. BMC Microbiol 10: 33
43. Molloy S. (2014). Bacterial physiology: a metabolic milieu. Nat Rev Microbiol 12: 315
44. Monge ME, Pérez JJ, Dwivedi P, Zhou M, McCarty NA, Stecenko AA, et al. (2013). Ion mobility and liquid chromatography/mass spectrometry strategies for exhaled breath condensate glucose quantitation in cystic fibrosis studies. Rapid Commun Mass Spectrom 27: 2263-2271
45. Montuschi P, Paris D, Melck D, Lucidi V, Ciabattoni G, Raia V, et al. (2012). NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax 67: 222-228
46. Moree WJ, Phelan VV, Wu C-H, Bandeira N, Cornett DS, Duggan BM, et al. (2012). Interkingdom metabolic transformations captured by microbial imaging mass spectrometry. PNAS 109: 13811-13816
47. Newport S, Amin N, Dozor AJ. (2009). Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations. Pediatr Pulmonol 872: 866-872
48. Nguyen DD, Wu C-H, Moree WJ, Lamsa A, Medema MH, Zhao X, et al. (2013). MS/MS networking guided analysis of molecule and gene cluster families. Proc Natl Acad Sci USA 110: E2611-E2620
49. Oksanen, Blanchet FG, Kindt R, Legendre P, Minchin PR, ROHara R, et al. (2015). Vegan: Community ecology. CRAN R Packag version 23-0. Available from http://CRAN.R-project.org/package=vegan
50. Olsen I, Jantzen E. (2001). Sphingolipids in bacteria and fungi. Anaerobe 7: 103-112
51. Palmer KL, Aye LM, Whiteley M. (2007). Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189: 8079-8087
52. Palmer KL, Mashburn LM, Singh PK, Whiteley M. (2005). Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187: 5267-5277
53. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, et al. (2005). Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 11: 491-498
54. Pierson LS, Pierson EA. (2010). Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes. Appl Microbiol Biotechnol 86: 1659-1670
55. Price KE, Hampton TH, Gifford AH, Dolben EL, Hogan DA, Morrison HG, et al. (2013). Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 1: 27
56. Price-Whelan A, Dietrich LEP, Newman DK. (2006). Rethinking secondary metabolism: physiological roles for phenazine antibiotics. Nat Chem Biol 2: 71-78
57. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. (2013). The SILVA ribosomal RNA gene database project: improved data processing and webbased tools. Nucleic Acids Res 41: D590-D596
58. Quinn RA, Lim YW, Maughan H, Conrad D, Rohwer F, Whiteson KL. (2014). Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung. MBio 5: e00956-13
59. Quinn RA, Whiteson K, Lim Y, Salamon P, Bailey B, Mienardi S, et al. (2014). A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation. ISME J 9: 1024-1038
60. Quinton PM. (1983). Chloride impermeability in cystic fibrosis. Nature 301: 421-422
61. Quinton PM. (2008). Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet 372: 415-417
62. Rada B, Lekstrom K, Damian S, Dupuy C, Leto TL. (2008). The Pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial system as it imposes oxidative stress on airway epithelial cells. J Immunol 181: 4883-4893
63. Riethmüller J, Anthonysamy J, Serra E, Schwab M, Döring G, Gulbins E. (2009). Therapeutic efficacy and safety of amitriptyline in patients with cystic fibrosis. Cell Physiol Biochem 24: 65-72
64. Robroeks CM, van Berkel J, Dallinga JW, Jöbsis Q, Zimmermann L, Hendriks HJ, et al. (2010). Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res 68: 75-80
65. Rogers GB, Hart CA, Mason JR, Hughes M, Walshaw MJ, Bruce KD. (2003). Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 41: 3548-3558
66. Sakata A, Ochiai T, Shimeno H, Hikishima S, Yokomatsu T, Shibuya S, et al. (2007). Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodiuminduced colitis in mice. Immunology 122: 54-64
67. Salipante SJ, Sengupta DJ, Rosenthal C, Costa G, Spangler J, Sims EH, et al. (2013). Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS One 8: e65226
68. Schertzer JW, Brown SA, Whiteley M. (2010). Oxygen levels rapidly modulate Pseudomonas aeruginosa social behaviours via substrate limitation of PqsH. Mol Microbiol 77: 1527-1538
69. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. (2009). Introducing mothur: opensource, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75: 7537-7541
70. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504
71. Sidebottom AM, Johnson AR, Karty JA, Trader DJ, Carlson EE. (2013). Integrated metabolomics approach facilitates discovery of an unpredicted natural product suite from Streptomyces coelicolor M145. ACS Chem Biol 8: 2009-2016
72. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407: 762-764
73. Smith DJ, Badrick AC, Zakrzewski M, Krause L, Bell SC, Anderson GJ, et al. (2014). Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics. Eur Respir J 44: 922-930
74. Sriramulu DD, Lünsdorf H, Lam JS, Römling U. (2005). Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 54: 667-676
75. Stites SW, Walters B, OBrien-Ladner A, Bailey K, Wesselius L. (1998). Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 114: 814
76. Sud M, Fahy E, Cotter D, Brown A, Dennis E, Glass C, et al. (2006). LMSD: lipid MAPS structure database. Nucleic Acids Res 35: D527-D532
77. Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA, et al. (2007). Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3: 211-221
78. Tabeling C, Yu H, Wang L, Ranke H, Goldenberg NM, Zabini D, et al. (2015). CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci USA 112: E1614-E1623
79. Teichgräber V, Ulrich M, Endlich N, Riethmüller J, Wilker B, De Oliveira-Munding CC, et al. (2008). Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14: 382-391
80. Telenga ED, Hoffmann RF, Ruben tKindt, Hoonhorst SJM, Willemse BWM, van Oosterhout AJM, et al. (2014). Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids. Am J Respir Crit Care Med 190: 155-164
81. Truan D, Vasil A, Stonehouse M, Vasil ML, Pohl E. (2013). High-level over-expression, purification, and crystallization of a novel phospholipase C/sphingomyelinase from Pseudomonas aeruginosa. Protein Expr Purif 90: 40-46
82. Turner KH, Wessel AK, Palmer GC, Murray JL, Whiteley M. (2015). Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum. Proc Natl Acad Sci USA 112: 4110-4115
83. Twomey KB, Alston M, An S-Q, OConnell OJ, McCarthy Y, Swarbreck D, et al. (2013). Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation. PLoS One 8: e82432
84. Watrous J, Roach P, Alexandrov T, Heath BS, Yang JY, Kersten RD, et al. (2012). Mass spectral molecular networking of living microbial colonies. Proc Natl Acad Sci USA 109: 1743-1752
85. Whiteson KL, Meinardi S, Lim YW, Schmieder R, Maughan H, Quinn R, et al. (2014). Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2, 3-butanedione fermentation. ISME J 8: 1247-1258
86. Widdicombe JH, Welsh MJ, Finkbeiner WE. (1985). Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. PNAS 82: 6167-6171
87. Wieland Brown LC, Penaranda C, Kashyap PC, Williams BB, Clardy J, Kronenberg M, et al. (2013). Production of α-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol 11: e1001610
88. Wilder CN, Allada G, Schuster M. (2009). Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect Immun 77: 5631-5639
89. Willger SD, Grim SL, Dolben EL, Shipunova A, Hampton TH, Morrison HG, et al. (2014). Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome 2: 40
90. Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, et al. (2009). Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PLoS One 4: e7370
91. Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, Rainey PB, et al. (2012). Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J 6: 471-474
92. Wolak JE, Esther CR, OConnell TM. (2009). Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers 14: 55-60
93. Workentine ML, Sibley CD, Glezerson B, Purighalla S, Norgaard-Gron JC, Parkins MD, et al. (2013). Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One 8: e60225
94. Yang J, Eiserich JP, Cross CE, Morrissey BM, Hammock BD. (2012). Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic Biol Med 53: 160-171
95. Yang JY, Sanchez LM, Rath CM, Liu X, Boudreau PD, Bruns N, et al. (2013). Molecular networking as a dereplication strategy. J Nat Prod 76: 1686-1699
96. Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, et al. (2013). Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One 8: e62917
97. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, et al. (2012). Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA 109: 5809-5814
98. Ziobro R, Henry B, Edwards MJ, Lentsch AB, Gulbins E. (2013). Ceramide mediates lung fibrosis in cystic fibrosis. Biochem Biophys Res Commun 434: 705-709
99. Zulianello L, Canard C, Köhler T, Caille D, Lacroix J-S, Meda P. (2006). Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect Immun 74: 3134-3147